Yemen - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Yemen Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 0.8% year on year. In 2019, the country was ranked number 181 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 51 Cases. India lead the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 51.00 |
| 2018 | 50.00 |
| 2017 | 43.00 |
| 2016 | 48.00 |
| 2015 | 23.00 |
Download all data from 2005 to 2019
How does Yemen rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 181 |
#181
Saudi Arabia
|
51 | 2019 | +2.0 % | -5.3 % | View data | |
| 181 |
#181
Yemen
|
51 | 2019 | +2.0 % | -0.8 % | View data | |
| 191 |
#191
Algeria
|
44 | 2017 | +41.9 % | NA | View data | |